Distinguished in Hepatocerebral Degeneration

Ferenc Szalay

Korányi Sándor Street 2, 
Budapest, BU, HU 
Distinguished in Hepatocerebral Degeneration
Korányi Sándor Street 2, 
Budapest, BU, HU 
OverviewLocationsClinical Research

Overview

Ferenc Szalay practices in Budapest, Hungary. Mr. Szalay is rated as a Distinguished expert by MediFind in the treatment of Hepatocerebral Degeneration. His top areas of expertise are Hepatocerebral Degeneration, Wilson Disease, Cirrhosis, and Hepatitis C.

His clinical research consists of co-authoring 40 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles and participated in 1 clinical trial in the study of Hepatocerebral Degeneration.

Gender
Male

Locations

Korányi Sándor Street 2, Budapest, BU 1083, Hungary

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Rater-Blinded, Multi-Center Study to Evaluate the Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Patients With Wilson Disease Aged 12 Years and Older, With an Extension Period of up to 60 Months
A Phase 3, Randomized, Rater-Blinded, Multi-Center Study to Evaluate the Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Patients With Wilson Disease Aged 12 Years and Older, With an Extension Period of up to 60 Months
Enrollment Status: Terminated
Publish Date: June 17, 2024
Intervention Type: Drug
Study Drug: ALXN1840
Study Phase: Phase 3

40 Total Publications

Serum fetuin-A is decreased in cirrhotic patients with Wilson's disease.
Serum fetuin-A is decreased in cirrhotic patients with Wilson's disease.
Journal: PloS one
Published: November 29, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Szalay's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile